Ouchi, Kota
Takahashi, Shin
Chikamatsu, Sonoko
Ito, Shukuei
Takahashi, Yoshikazu
Kawai, Sadayuki
Okita, Akira
Kasahara, Yuki
Okada, Yoshinari
Imai, Hiroo
Komine, Keigo
Saijo, Ken
Takahashi, Masahiro
Shirota, Hidekazu
Takahashi, Masanobu
Gamoh, Makio
Ishioka, Chikashi
Article History
Received: 9 November 2017
Accepted: 27 February 2018
First Online: 7 March 2018
Compliance with ethical standards
:
: Chikashi Ishioka has received research funding from the Tokyo Cooperative Oncology Group. Chikashi Ishioka has also received contributions from Chugai Pharmaceutical, Ono pharmaceutical, MSD, Phizer, AstraZeneca, Bristol-Myers squibb, Janssen Pharmaceutical, Taiho Pharmaceutical, Daiichi Sankyo Company, Limited, and Takeda Pharmaceutical. Shin Takahashi has received research funding from Merck Serono Company. Masanobu Takahashi has received research funding from Ono Pharmaceutical Company. Masanobu Takahashi is a member of a committee of Tohoku Clinical Oncology Research and Education Society, a specified non-profit corporation. Chikashi Ishioka is a representative of Tohoku Clinical Oncology Research and Education Society, a specified non-profit corporation.